Work

Abstract PS2-06-03: Sacituzumab Govitecan Dosing and Neutropenia Risk in Patients with HER2-Negative Metastatic Breast Cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-06-03

Authors: A. B. Newman, A. Raghavendra, E. Grannan, F. Meric-Bernstam, D. Tripathy, J. Litton, S. Damodaran

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130720160

Cites:

Cited by:

Related to: